
Medical Technology Enterprise Consortium: Pioneering commercial physical and biological R&D since 2015.
mtec-sc.orgCrawled Oct 15, 2026
Defeat antibiotic resistance with rapid diagnostics, targeted antibiotics and biofilm strategies and stewardship to sustain Warfighter readiness in austere settings.
The page describes MTEC’s capabilities in accelerating medical technology development for military and civilian applications.
The company advances the rapid deployment of medical technologies intended to improve the health of military personnel and civilians.
MTEC Patents - tools and services to discover, manage, and commercialize breakthrough technologies.
Presenters: Chris Danek, PhD, MBA, CEO, Bessel, and Andres Gutierrez, Program Director, Bessel.
Tensentric provides turnkey design, development, and contract manufacturing for healthcare, diagnostics, and life sciences technologies. The session outlines a roadmap for turning medical technology into a commercially viable, FDA-compliant product.
The Conafay Group presents a mid-year analysis of federal funding for health, defense health, and biosecurity, covering FY27 appropriations, the defense authorization, and near-term priorities.
Oliver Healthcare Packaging presents a webinar on sterile barrier packaging and five ways HDPE CleanCut Cards can help accelerate development timelines while protecting medical devices.
Congratulations to Applied Research Associates (ARA) for receiving the 2022 MTEC Impact Award, which recognizes an MTEC member’s outstanding support of a high-impact military need.
Astrocyte Pharmaceuticals has begun a Phase 1 trial for AST-004, a potential treatment for stroke, TBI, and neurodegenerative diseases. The study, funded partly by MTEC and the U.S. Army, will assess safety in 52 healthy participants. If successful, it will progress to Phase 2 trials.
BiomX reported positive Phase 2 results for BX211, a personalized phage therapy for diabetic foot osteomyelitis. The treatment improved ulcer healing and may reduce amputation risk.
With MTEC support, Delta Development Team advanced its Single Unit Blood Warmer (SUBW)—a battery-powered, field-ready device—for FDA 510(k) clearance. Designed for military use, SUBW efficiently warms blood without disposables.
MTEC’s Prototype Acceleration Bridge Loan program funds member medical technology development to reduce risk and advance readiness for follow-on funding.
The Medical Technology Enterprise Consortium collaborates with government agencies under a renewable Other Transaction Agreement with the U.S. Army Medical Research and Development Command and develops medical solutions for U.S. military personnel and civilians.
Medical Technology Enterprise Consortium, MTEC, military medical innovation, DoD medical research, OTA funding, biomedical technology consortium, medical technology development, military health solutions, civilian health innovation, MTEC membership.
The page explains how MTEC collects, uses, and protects personal information from website interactions.